Sawaguchi et al., D1 Dopamine Receptors in Prefontal Cortex: Involvement in Working Memory; Feb. 1991, Science vol. 251. |
Meltzer; Novel Approaches to the Pharmacotherapy of Schizophrenia; Drug Development Research 9:23-40 (1986). |
Del Zompo, Dopamine Agonists in the Treatment of Schizophrenia; Progress in Brain Research vol. 65 (1986). |
Levy; The Dopamine Theory OPF Attention Deficit Hyperactivity Disorder (ADHD) Australian and New Zealand Journal of Psychiatry 1991; 25:277-283. |
Britton et al., Evidence for Involvement of Both D1 and D2 Receptors in Maintaining Cocaine Self-Administration, Parma Biochemistry & Behavior vol. 39, pp. 911-915 (1991). |
Anderson et al., Thienopyridine Derivatives Identified as the First Selective, Full Efficacy, Dopamine D1 Receptor Agonists; European Journal of Pharmacology 137(1987) 291-292. |
Kiguchi et al., A Route for Total Synthesis of Ergot Alkaloids Synthesis of the Desphyrrole Analogs of Methyl Lysergate, Isolysergol, and Isofumigtclavine A.; Heterocycles vol. 19, No. 10, 1982. |
Effects of the D1 Agonist SKF-38393 Combined with Haloperidol in Schizophrenic Patients; Arch Gen Psychiatry vol. 47, Feb. 1990. |
Muscat et al., Antidepressant-like effects of Dopamine Agonists in an Animal Model of Depression; Biol Psychiatry 1992;31:937-946. |
Asin et al, Repeated D1 Receptor Agonist Treatment Blocks Cocaine-Induced Locomotor Activity and C-FOS Expression; Brain Research 637(1994) 342-344. |
Reynolds, et al., Developments in the Drug Treatment of Schizophrenia; Trends in Pharmacological Sciences, 1992, 13(3), pp. 116-121. |
Sibley et al., Molecular Biology of Dopamine Receptors; TIPS, 1992, 13(2) pp. 61-69. |
Arnsten et al., Dopamine D1 Receptor Mechanisms in the Cognitive Performance of Young Adult and Aged Monkeys; Psychopharmacology (1994) 116:143-151. |
Katz et al; Selective Effects of the D1 Dopamine Receptor Agonist, SKF 38393, on Behavior Maintained by Cocaine Injection in Squirrel Monkeys; Psychopharmacology (1992) 109;241-244. |
Katerinopoulos et al., Structure Activity Relationships for Dopamine Analogs: A Review; Drugs of the Future vol. 12, No. 3 1987. |
Lokhandwala; Preclinical and Clinical Studies on the Cardiovascular and Renal Effects of Fenoldopam a DA1 Receptor Agonist; Drug Devel. Research 10:123-134(1987). |
Kaiser et al; Dopamine Receptors: Functions, Subtypes and Emerging Concepts; Medicinal Research Reviews vol. 5, No. 2, 145-229 (1985). |
Wise et al, Brain Dopamine and Reward; Ann Rev. Psychol 1989 40:191-225. |